Shandong Wit Dyne Health Co.,Ltd. (SHE:000915)
31.35
+0.19 (0.61%)
Feb 3, 2026, 3:04 PM CST
Shandong Wit Dyne Health Revenue
Shandong Wit Dyne Health had revenue of 432.12M CNY in the quarter ending September 30, 2025, with 93.28% growth. This brings the company's revenue in the last twelve months to 2.36B, up 10.06% year-over-year. In the year 2024, Shandong Wit Dyne Health had annual revenue of 2.13B, down -14.08%.
Revenue (ttm)
2.36B
Revenue Growth
+10.06%
P/S Ratio
3.11
Revenue / Employee
1.34M
Employees
1,759
Market Cap
7.35B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.13B | -349.67M | -14.08% |
| Dec 31, 2023 | 2.48B | 143.09M | 6.11% |
| Dec 31, 2022 | 2.34B | 313.93M | 15.49% |
| Jan 1, 2022 | 2.03B | 206.11M | 11.32% |
| Dec 31, 2020 | 1.82B | 21.09M | 1.17% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Northeast Pharmaceutical Group | 6.85B |
| Cisen Pharmaceutical | 3.56B |
| Hunan Jiudian Pharmaceutical | 3.05B |
| Guangxi Wuzhou Zhongheng Group | 2.29B |
| HARBIN GLORIA PHARMACEUTICALS Co., LTD | 2.25B |
| Jiuzhitang | 1.94B |
| Heilongjiang ZBD Pharmaceutical | 1.59B |
| Hunan Er-Kang Pharmaceutical | 1.29B |